GaoLing Pharma's Class 1 New Drug HL-400 for Parkinson’s Disease Receives Clinical Trial Approval in China
May 27, 2026 15:47
CST Updated
18:12
Highlightll Pharma
Innovative Drug Developer
Innovative Drug Developer